Skip to content

Bernard Le Foll

17 papers in the library · 33 citations · publishing 0-2026

Papers

Sort Most recent Most cited

Investigating sex differences in the acute effects of smoked cannabis: a potency-ranging, controlled administration, human laboratory experiment.

Psychopharmacology August 11, 2026 Madison Wright, Justin Matheson, Adam Zaweel et al.

RATIONALE Sex differences in the effects of cannabis have been demonstrated in animals, though the human evidence is more equivocal. In particular, more work is needed to better understand interactions between sex and dose in determining acute pharmacological effects of cannabis, especially at higher potencies of Δ9-tetrahydrocannabinol (THC). OBJECTIVES Sex differences were examined following...

PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.

Neuropsychopharmacology May 9, 2026 Claudia Poluga, S. S. Dheda, Nadia Boachie et al.

Cannabis withdrawal in cannabis use disorder (CUD) increase the risk of relapse and lacks effective treatments. The endocannabinoid enzyme fatty acid amide hydrolase (FAAH) may influence cannabis use and withdrawal, but the relationship between FAAH levels and withdrawal symptoms remains unclear. This study aims to investigate changes in FAAH levels during short-term abstinence from cannabis...

Potency-related effects of smoked cannabis on simulated driving performance: a randomized, controlled crossover trial.

Scientific Reports March 10, 2026 Bruna Brands, Adam Zaweel, Madison Wright et al.

Given the increasing availability of high-potency Δ9-tetrahydrocannabinol (Δ9-THC) products, understanding potency-related effects of Δ9-THC on driving performance is an important public safety issue. This randomized, double-blind, placebo-controlled, within-subjects trial examined the effects of smoked cannabis with varying Δ9-THC concentrations on simulated driving. Adults aged 19–45 who...

Effects of naturalistic doses of cannabis edibles on cognition and association with blood THC.

Psychopharmacology March 1, 2026 Patricia Di Ciano, Sampson Zhao, Pamela Kaduri et al. 2 citations

Smoked cannabis is known to have effects on cognitive function. The use of edibles is on the rise yet there are few studies of the effects of edibles on cognitive function. Further, most studies of cannabis used fixed laboratory doses which may not capture some of the nuances of more naturalistic doses. Delta-9-tetrahydrocannabinol (THC) is the psychoactive component of cannabis yet the...

The effects of naturalistic cannabis use on cognition and subjective experience in older adults with normal cognitive function

Journal of Psychopharmacology November 3, 2025 Patricia Di Ciano, Bernard Le Foll, S. Zhao et al.

Background: Adults over the age of 65 years are the fastest growing group of cannabis users, but there are few studies of the acute effects of cannabis in this population. Aims: In the present naturalistic study, participants were invited to smoke their preferred legal cannabis in the lab prior to tests of verbal learning and memory, executive function and information processing, and functional...

Sex differences in the acute effects of cannabis on human cognition: A systematic review.

Frontiers in neuroendocrinology October 1, 2025 Justin Matheson, Danial Behzad, Christina Zakala et al. 5 citations

Acute cannabis exposure can transiently impair cognitive performance, increasing the risk of accidental injury and potentially disrupting activities of daily living. Although sex differences in responses to cannabis have been reported, no systematic review has examined whether these extend to acute cognitive effects. Our primary aim was to examine sex differences in the acute effects of...

The effect of cannabis edibles on driving and blood THC.

Journal of Cannabis Research May 31, 2024 S Zhao, Bruna Brands, Pamela Kaduri et al. 13 citations

Cannabis has been shown to impact driving due to changes produced by delta-9-tetrahydrocannabinol (THC), the psychoactive component of cannabis. Current legal thresholds for blood THC while driving are based predominantly on evidence utilizing smoked cannabis. It is known that levels of THC in blood are lower after eating cannabis as compared to smoking yet the impact of edibles on driving and...

DOI: 10.1186/s42238-024-00234-y (opens in new tab) Full text (opens in new tab) Addiction medicine Blood Cannabis edibles Pharmacology and toxicology +3

Cannabis Use Characteristics Associated with Self-Reported Cognitive Function in a Nationally Representative U.S. sample

Substance Use & Misuse April 25, 2024 D. Rubin-Kahana, Kevin Butler, A. Hassan et al.

Abstract Background With increases in cannabis use and potency, there is a need to improve our understanding of the impact of use on cognitive function. Previous research indicates long-term cannabis use may have a negative effect on executive function. Few studies have examined persistence of it in protracted abstinence, and there is limited evidence of predictors of worse cognitive function...

The acceptability and feasibility of a virtual mantram program for patients with posttraumatic stress disorder and substance use disorders: mixed method results.

BMC Complementary Medicine and Therapies January 2, 2024 Sean Ferkul, Zena Agabani, Osamu Minami et al. 8 citations

There is a need for expanded options for therapeutic interventions for patients with posttraumatic stress disorder (PTSD) and substance use disorder (SUD). The study aimed to examine evidence for the feasibility, safety, and acceptability of a virtual Mantram Repetition Program for adults with PTSD and SUD. This project utilized mixed-method design (explanatory sequential design) to collect...

Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies.

Psychopharmacology July 1, 2023 Ke Bin Xiao, Erin Grennell, Anthony Ngoy et al.

Cannabis self-administration studies may be helpful for identifying factors that influence cannabis consumption and subjective response to cannabis. Additionally, these paradigms could be useful for testing novel pharmacotherapies for cannabis use disorder. This scoping review aims to summarize the findings from existing ad libitum cannabis self-administration studies to determine what has been...

DOI: 10.1007/s00213-023-06360-4 (opens in new tab) Full text (opens in new tab) Ad libitum Cannabis smoking Free-access Human laboratory +2

The Acceptability and Feasibility of a Virtual Mantram Program for Patients with Posttraumatic Stress Disorder and Substance Use Disorders: Mixed Method results

Research Square March 20, 2023 Ahmed N. Hassan, Sean Ferkul, Zena Agabani et al. preprint

Abstract Background : There is a need for expanded options for therapeutic interventions for patients with posttraumatic stress disorder (PTSD) and substance use disorder (SUD). The study aimed to examine evidence for the feasibility, safety, and acceptability of a virtual Mantram Repetition Program for adults with PTSD and SUD. Methods : This project utilized mixed-method design (explanatory...

DOI: 10.21203/rs.3.rs-2605978/v1 (opens in new tab) Full text (opens in new tab) Mindfulness Psychological intervention Substance abuse Clinical psychology +3

Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review.

Biomolecules October 12, 2022 Justin Matheson, Zoe Bourgault, Bernard Le Foll

Cannabidiol (CBD) is a non-intoxicating cannabinoid compound with diverse molecular targets and potential therapeutic effects, including effects relevant to the treatment of psychiatric disorders. In this scoping review, we sought to determine the extent to which sex and gender have been considered as potential moderators of the neuropsychiatric effects and pharmacokinetics of CBD. In this...

Association between ABCB1 rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults

Brain Sciences September 3, 2022 Justin Matheson, Yollanda J. Zhang, Bruna Brands et al. 5 citations

Genetic influences on acute responses to psychoactive drugs may contribute to individual variability in addiction risk. ABCB1 is a human gene that encodes P-glycoprotein, an ATP-dependent efflux pump that may influence the pharmacokinetics of delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. Using data from 48 young adults (aged 19–25 years) reporting 1–4 days...

DOI: 10.3390/brainsci12091189 (opens in new tab) Cannabis Delta-9-tetrahydrocannabinol Pharmacokinetics Genotype +6

Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial.

Progress in Neuro-Psychopharmacology and Biological Psychiatry May 1, 2022 Christine M Wickens, Madison Wright, Robert E Mann et al.

Co-use of alcohol and cannabis is associated with increased frequency and intensity of use and related problems. This study examined acute effects of alcohol and cannabis on mood, subjective experience, cognition, and psychomotor performance. Twenty-eight healthy cannabis users aged 19-29 years with recent history of binge drinking completed this within-subjects, double-blind, double-dummy,...

Combined effect of alcohol and cannabis on simulated driving.

Psychopharmacology May 2022 Andrew Fares, Christine M Wickens, Robert E Mann et al.

With alcohol and cannabis remaining the most commonly detected drugs in seriously and fatally injured drivers, there is a need to understand their combined effects on driving. The present study examined the effects of combinations of smoked cannabis (12.5% THC) and alcohol (target BrAC 0.08%) on simulated driving performance, subjective drug effects, cardiovascular measures, and self-reported...

Sex differences in the acute pharmacological and subjective effects of smoked cannabis combined with alcohol in young adults.

Psychology of Addictive Behaviors June 3, 2021 Madison Wright, Christine M Wickens, Patricia Di Ciano et al.

Objective: The prevalence of co-use of alcohol and cannabis is increasing, particularly among young adults. Sex differences in the effects of alcohol alone and cannabis alone have been observed in animals and humans. However, sex differences in the acute pharmacological effects of cannabis combined with alcohol have not yet been studied. In young adults, aged 19-29 years, we aimed to examine...

Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report.

Journal of Addiction Medicine Dafna Sara Rubin-Kahana, Ahmed Nabeel Hassan, Bernard Le Foll

In the last 2 decades, there is a renaissance in the scientific investigation of the therapeutic potential of psychedelic compounds. It is studied for the treatment of many psychiatric disorders, including posttraumatic stress disorder. The treatment is always done in the setting of psychedelic-assisted psychotherapy. A little is known about the potential effects, outside of the setting of...